UCSF |

The Kidney Project successfully tests a prototype bioartificial kidney

Taking another big step toward becoming reality, Shuvo Roy's project is awarded KidneyX’s Artificial Kidney Prize.

UC Riverside |

Grow and eat your own vaccines?

A new project will study whether edible plants like lettuce into mRNA vaccine factories.

UC San Diego |

It’s not just SARS-CoV-2: Most respiratory viruses spread by aerosols

Our conventional wisdom on viral disease transmission needs revision, an international science team finds.

UC Riverside via The Conversation |

How the Purdue opioid settlement could help the public understand the roots of the drug crisis

The multibillion-dollar settlement will trigger the release of troves of documents that may shine new light on what caused the opioid crisis.

UC Davis |

Both sucrose and high fructose corn syrup linked to increased health risks

Sucrose, a more 'natural' form of sugar, may be just as bad for your health.

UCSF |

Struggling to learn a new language? Blame it on your stable brain

A new study sheds light on the age-old question of why it’s so difficult to learn a second language as an adult.

UC Berkeley |

How much wildfire smoke is infiltrating our homes?

Scientists investigate what homes are best at keeping the smoke out and what we can do to keep our air cleaner.

UCSF |

COVID-19 during pregnancy associated with preterm birth

People of color face disproportionate infection risk while pregnant, large study finds.

UC Davis |

LGBTQ+ youth face increased anxiety amid COVID-19 pandemic

Using social media, research identifies stressors among an already vulnerable population.

UC San Diego |

Second breath: Region’s first double lung transplant for COVID-19 patient

Facing a ventilator-bound future, Federico Gomez Gil can finally breathe freely again, thanks to the help of a UC San Diego Health team.

UC Berkeley |

Using two CRISPR enzymes, a COVID diagnostic in only 20 minutes

Eliminating RNA amplification simplifies and speeds up assay for SARS-CoV-2 virus, making it ideal for point of care testing.

UCSF |

Can this controversial new drug curb Alzheimer’s disease?

It’s complicated, but for some patients, there’s reason to be optimistic about aducanumab, the treatment that made waves upon receiving FDA approval this summer.